nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Coma hepatic—Ritonavir—acquired immunodeficiency syndrome	0.0617	0.0962	CcSEcCtD
Fluoxymesterone—Cholesterol serum elevated—Indinavir—acquired immunodeficiency syndrome	0.0599	0.0933	CcSEcCtD
Fluoxymesterone—SHBG—semen—acquired immunodeficiency syndrome	0.0514	0.169	CbGeAlD
Fluoxymesterone—AR—semen—acquired immunodeficiency syndrome	0.0369	0.121	CbGeAlD
Fluoxymesterone—Blood cholesterol increased—Nelfinavir—acquired immunodeficiency syndrome	0.0285	0.0445	CcSEcCtD
Fluoxymesterone—Blood cholesterol increased—Indinavir—acquired immunodeficiency syndrome	0.023	0.0358	CcSEcCtD
Fluoxymesterone—Blood cholesterol increased—Efavirenz—acquired immunodeficiency syndrome	0.0217	0.0339	CcSEcCtD
Fluoxymesterone—Clotting—Saquinavir—acquired immunodeficiency syndrome	0.0209	0.0325	CcSEcCtD
Fluoxymesterone—PRLR—brain—acquired immunodeficiency syndrome	0.0197	0.0647	CbGeAlD
Fluoxymesterone—SHBG—blood plasma—acquired immunodeficiency syndrome	0.0187	0.0615	CbGeAlD
Fluoxymesterone—Seborrhoeic dermatitis—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0212	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Saquinavir—acquired immunodeficiency syndrome	0.0135	0.021	CcSEcCtD
Fluoxymesterone—NR3C1—nerve—acquired immunodeficiency syndrome	0.0129	0.0423	CbGeAlD
Fluoxymesterone—Seborrhoeic dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.0123	0.0191	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.0114	0.0177	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.0109	0.017	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Stavudine—acquired immunodeficiency syndrome	0.0102	0.016	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Didanosine—acquired immunodeficiency syndrome	0.00989	0.0154	CcSEcCtD
Fluoxymesterone—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.00973	0.032	CbGeAlD
Fluoxymesterone—Coagulopathy—Saquinavir—acquired immunodeficiency syndrome	0.00957	0.0149	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00953	0.0149	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Zidovudine—acquired immunodeficiency syndrome	0.00891	0.0139	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Ritonavir—acquired immunodeficiency syndrome	0.00881	0.0137	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Efavirenz—acquired immunodeficiency syndrome	0.00783	0.0122	CcSEcCtD
Fluoxymesterone—PRLR—Nuclear signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.00745	0.137	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Indinavir—acquired immunodeficiency syndrome	0.00694	0.0108	CcSEcCtD
Fluoxymesterone—SHBG—blood—acquired immunodeficiency syndrome	0.00686	0.0225	CbGeAlD
Fluoxymesterone—SHBG—bone marrow—acquired immunodeficiency syndrome	0.00664	0.0218	CbGeAlD
Fluoxymesterone—Libido decreased—Delavirdine—acquired immunodeficiency syndrome	0.00655	0.0102	CcSEcCtD
Fluoxymesterone—AR—skin of body—acquired immunodeficiency syndrome	0.00646	0.0212	CbGeAlD
Fluoxymesterone—Gynaecomastia—Lamivudine—acquired immunodeficiency syndrome	0.00636	0.00991	CcSEcCtD
Fluoxymesterone—SHBG—vagina—acquired immunodeficiency syndrome	0.00636	0.0209	CbGeAlD
Fluoxymesterone—Libido decreased—Ritonavir—acquired immunodeficiency syndrome	0.00606	0.00945	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Delavirdine—acquired immunodeficiency syndrome	0.00603	0.0094	CcSEcCtD
Fluoxymesterone—Alopecia—Didanosine—acquired immunodeficiency syndrome	0.00585	0.00913	CcSEcCtD
Fluoxymesterone—Libido decreased—Saquinavir—acquired immunodeficiency syndrome	0.00583	0.00909	CcSEcCtD
Fluoxymesterone—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.0058	0.00904	CcSEcCtD
Fluoxymesterone—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.00577	0.009	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Ritonavir—acquired immunodeficiency syndrome	0.00557	0.00869	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Saquinavir—acquired immunodeficiency syndrome	0.00536	0.00836	CcSEcCtD
Fluoxymesterone—SHBG—central nervous system—acquired immunodeficiency syndrome	0.00536	0.0176	CbGeAlD
Fluoxymesterone—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.00523	0.0172	CbGeAlD
Fluoxymesterone—AR—digestive system—acquired immunodeficiency syndrome	0.00517	0.017	CbGeAlD
Fluoxymesterone—ESR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00513	0.0169	CbGeAlD
Fluoxymesterone—ESR1—digestive system—acquired immunodeficiency syndrome	0.00507	0.0167	CbGeAlD
Fluoxymesterone—Alopecia—Abacavir—acquired immunodeficiency syndrome	0.00501	0.00781	CcSEcCtD
Fluoxymesterone—AR—blood—acquired immunodeficiency syndrome	0.00492	0.0162	CbGeAlD
Fluoxymesterone—ESR1—blood—acquired immunodeficiency syndrome	0.00483	0.0159	CbGeAlD
Fluoxymesterone—AR—spinal cord—acquired immunodeficiency syndrome	0.00474	0.0156	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00471	0.00734	CcSEcCtD
Fluoxymesterone—NR3C1—skin of body—acquired immunodeficiency syndrome	0.00468	0.0154	CbGeAlD
Fluoxymesterone—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.00467	0.00729	CcSEcCtD
Fluoxymesterone—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.00465	0.00725	CcSEcCtD
Fluoxymesterone—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.00464	0.00723	CcSEcCtD
Fluoxymesterone—AR—vagina—acquired immunodeficiency syndrome	0.00456	0.015	CbGeAlD
Fluoxymesterone—ESR1—vagina—acquired immunodeficiency syndrome	0.00448	0.0147	CbGeAlD
Fluoxymesterone—AR—lung—acquired immunodeficiency syndrome	0.00432	0.0142	CbGeAlD
Fluoxymesterone—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.00426	0.00664	CcSEcCtD
Fluoxymesterone—SHBG—brain—acquired immunodeficiency syndrome	0.00426	0.014	CbGeAlD
Fluoxymesterone—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.00425	0.00662	CcSEcCtD
Fluoxymesterone—ESR1—lung—acquired immunodeficiency syndrome	0.00424	0.0139	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00423	0.0066	CcSEcCtD
Fluoxymesterone—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.00423	0.00659	CcSEcCtD
Fluoxymesterone—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.00418	0.00652	CcSEcCtD
Fluoxymesterone—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.00411	0.00641	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00403	0.00628	CcSEcCtD
Fluoxymesterone—AR—nervous system—acquired immunodeficiency syndrome	0.004	0.0131	CbGeAlD
Fluoxymesterone—ESR1—nervous system—acquired immunodeficiency syndrome	0.00392	0.0129	CbGeAlD
Fluoxymesterone—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00391	0.00609	CcSEcCtD
Fluoxymesterone—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00389	0.00606	CcSEcCtD
Fluoxymesterone—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.00388	0.00605	CcSEcCtD
Fluoxymesterone—AR—central nervous system—acquired immunodeficiency syndrome	0.00385	0.0126	CbGeAlD
Fluoxymesterone—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.0038	0.00593	CcSEcCtD
Fluoxymesterone—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.00379	0.0124	CbGeAlD
Fluoxymesterone—ESR1—central nervous system—acquired immunodeficiency syndrome	0.00378	0.0124	CbGeAlD
Fluoxymesterone—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00376	0.00586	CcSEcCtD
Fluoxymesterone—NR3C1—digestive system—acquired immunodeficiency syndrome	0.00374	0.0123	CbGeAlD
Fluoxymesterone—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00374	0.00583	CcSEcCtD
Fluoxymesterone—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.00371	0.00579	CcSEcCtD
Fluoxymesterone—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00369	0.00576	CcSEcCtD
Fluoxymesterone—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00368	0.00574	CcSEcCtD
Fluoxymesterone—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00367	0.00572	CcSEcCtD
Fluoxymesterone—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00361	0.00564	CcSEcCtD
Fluoxymesterone—NR3C1—blood—acquired immunodeficiency syndrome	0.00356	0.0117	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00355	0.00554	CcSEcCtD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.0035	0.0646	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00347	0.00541	CcSEcCtD
Fluoxymesterone—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.00345	0.0113	CbGeAlD
Fluoxymesterone—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.00343	0.0113	CbGeAlD
Fluoxymesterone—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00343	0.00535	CcSEcCtD
Fluoxymesterone—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.00331	0.00515	CcSEcCtD
Fluoxymesterone—NR3C1—vagina—acquired immunodeficiency syndrome	0.0033	0.0109	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.0033	0.00515	CcSEcCtD
Fluoxymesterone—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00324	0.00506	CcSEcCtD
Fluoxymesterone—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00323	0.00504	CcSEcCtD
Fluoxymesterone—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00319	0.00497	CcSEcCtD
Fluoxymesterone—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00315	0.00492	CcSEcCtD
Fluoxymesterone—NR3C1—lung—acquired immunodeficiency syndrome	0.00313	0.0103	CbGeAlD
Fluoxymesterone—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00312	0.00486	CcSEcCtD
Fluoxymesterone—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.0031	0.00484	CcSEcCtD
Fluoxymesterone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00307	0.00478	CcSEcCtD
Fluoxymesterone—AR—brain—acquired immunodeficiency syndrome	0.00305	0.01	CbGeAlD
Fluoxymesterone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00302	0.00471	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00301	0.00469	CcSEcCtD
Fluoxymesterone—ESR1—brain—acquired immunodeficiency syndrome	0.003	0.00985	CbGeAlD
Fluoxymesterone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00297	0.00462	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00297	0.00462	CcSEcCtD
Fluoxymesterone—AR—lymph node—acquired immunodeficiency syndrome	0.00295	0.00969	CbGeAlD
Fluoxymesterone—Headache—Didanosine—acquired immunodeficiency syndrome	0.00295	0.0046	CcSEcCtD
Fluoxymesterone—ESR1—lymph node—acquired immunodeficiency syndrome	0.0029	0.00952	CbGeAlD
Fluoxymesterone—NR3C1—nervous system—acquired immunodeficiency syndrome	0.00289	0.00951	CbGeAlD
Fluoxymesterone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00287	0.00448	CcSEcCtD
Fluoxymesterone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.0028	0.00437	CcSEcCtD
Fluoxymesterone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.0028	0.00436	CcSEcCtD
Fluoxymesterone—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.00279	0.00915	CbGeAlD
Fluoxymesterone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00276	0.00431	CcSEcCtD
Fluoxymesterone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00268	0.00418	CcSEcCtD
Fluoxymesterone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00265	0.00413	CcSEcCtD
Fluoxymesterone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00264	0.00411	CcSEcCtD
Fluoxymesterone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00257	0.004	CcSEcCtD
Fluoxymesterone—Headache—Stavudine—acquired immunodeficiency syndrome	0.00256	0.00399	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00254	0.00395	CcSEcCtD
Fluoxymesterone—Headache—Abacavir—acquired immunodeficiency syndrome	0.00252	0.00393	CcSEcCtD
Fluoxymesterone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00251	0.00392	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.00251	0.0463	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00248	0.00387	CcSEcCtD
Fluoxymesterone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00243	0.0038	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00243	0.00379	CcSEcCtD
Fluoxymesterone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00243	0.00378	CcSEcCtD
Fluoxymesterone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00239	0.00373	CcSEcCtD
Fluoxymesterone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00239	0.00372	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.0023	0.00358	CcSEcCtD
Fluoxymesterone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00228	0.00355	CcSEcCtD
Fluoxymesterone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00223	0.00347	CcSEcCtD
Fluoxymesterone—NR3C1—brain—acquired immunodeficiency syndrome	0.00221	0.00727	CbGeAlD
Fluoxymesterone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.0022	0.00343	CcSEcCtD
Fluoxymesterone—NR3C1—lymph node—acquired immunodeficiency syndrome	0.00214	0.00702	CbGeAlD
Fluoxymesterone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00211	0.00329	CcSEcCtD
Fluoxymesterone—Headache—Indinavir—acquired immunodeficiency syndrome	0.00207	0.00323	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00203	0.00317	CcSEcCtD
Fluoxymesterone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00196	0.00306	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00196	0.00305	CcSEcCtD
Fluoxymesterone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00196	0.00305	CcSEcCtD
Fluoxymesterone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00187	0.00292	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00187	0.00291	CcSEcCtD
Fluoxymesterone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00185	0.00289	CcSEcCtD
Fluoxymesterone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00177	0.00277	CcSEcCtD
Fluoxymesterone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00173	0.0027	CcSEcCtD
Fluoxymesterone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.0026	CcSEcCtD
Fluoxymesterone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.00256	CcSEcCtD
Fluoxymesterone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00159	0.00248	CcSEcCtD
Fluoxymesterone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00158	0.00246	CcSEcCtD
Fluoxymesterone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00235	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.00147	0.0272	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.0014	0.0258	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.00138	0.0254	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.00115	0.0213	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.00111	0.0205	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.00106	0.0196	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00102	0.0188	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000829	0.0153	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TNF—acquired immunodeficiency syndrome	0.00082	0.0151	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	0.000767	0.0141	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	0.000686	0.0127	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MBL2—acquired immunodeficiency syndrome	0.000682	0.0126	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—CD4—acquired immunodeficiency syndrome	0.000673	0.0124	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.000664	0.0122	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IL6—acquired immunodeficiency syndrome	0.000662	0.0122	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.000656	0.0121	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.000654	0.0121	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.000646	0.0119	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.000646	0.0119	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.000636	0.0117	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—acquired immunodeficiency syndrome	0.000628	0.0116	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000618	0.0114	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000618	0.0114	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.000611	0.0113	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.000609	0.0112	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	0.000591	0.0109	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000584	0.0108	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	0.000582	0.0107	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	0.000569	0.0105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.00056	0.0103	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000559	0.0103	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CCR2—acquired immunodeficiency syndrome	0.000534	0.00986	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	0.000507	0.00935	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000482	0.00889	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000481	0.00888	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.000471	0.00869	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD79A—acquired immunodeficiency syndrome	0.000467	0.00862	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000454	0.00838	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000447	0.00826	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	0.000399	0.00737	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.00039	0.0072	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000384	0.00709	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000382	0.00705	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000381	0.00703	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CSF2—acquired immunodeficiency syndrome	0.000377	0.00695	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD8A—acquired immunodeficiency syndrome	0.000377	0.00695	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000371	0.00685	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000365	0.00674	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000362	0.00669	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	0.000358	0.00661	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	0.000355	0.00655	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000353	0.00652	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.000347	0.0064	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000346	0.00638	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000344	0.00635	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.000342	0.0063	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	0.000339	0.00625	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000325	0.006	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000325	0.006	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.000301	0.00555	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000247	0.00456	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000243	0.00449	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000234	0.00431	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.000232	0.00428	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFNG—acquired immunodeficiency syndrome	0.000224	0.00413	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000223	0.00411	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD4—acquired immunodeficiency syndrome	0.000216	0.00399	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000204	0.00376	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000201	0.00371	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—acquired immunodeficiency syndrome	0.000199	0.00367	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000192	0.00354	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.000179	0.0033	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	0.000177	0.00326	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.000176	0.00325	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000173	0.00319	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—acquired immunodeficiency syndrome	0.000152	0.0028	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000147	0.00271	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000139	0.00257	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000131	0.00242	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000129	0.00237	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—acquired immunodeficiency syndrome	0.000122	0.00226	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—acquired immunodeficiency syndrome	0.000117	0.00216	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000116	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000116	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000113	0.00209	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.00011	0.00202	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000106	0.00195	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000105	0.00194	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.56e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.17e-05	0.00132	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.49e-05	0.0012	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.1e-05	0.00113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.1e-05	0.00113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.64e-05	0.000857	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.57e-05	0.000844	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.18e-05	0.000772	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.42e-05	0.000446	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000262	CbGpPWpGaD
